| Literature DB >> 27589714 |
Shuxia Yan1,2, Xianan Zhang3,4, Xin Wen5,6, Qiang Lv7,8, Changjie Xu9,10, Chongde Sun11,12, Xian Li13,14.
Abstract
Chinese bayberry (Morella rubra Sieb. et Zucc.) fruit have a diverse flavonoid composition responsible for the various medicinal activities, including anti-diabetes. In the present study, efficient simultaneous purification of four flavonoid glycosides, i.e., cyanidin-3-O-glucoside (1), myricetin-3-O-rhamnoside (2), quercetin-3-O-galactoside (3), quercetin-3-O-rhamnoside (4), from Chinese bayberry pulp was established by the combination of solid phase extract (SPE) by C18 Sep-Pak(®) cartridge column chromatography and semi-preparative HPLC (Prep-HPLC), which was followed by HPLC and LC-MS identification. The purified flavonoid glycosides, as well as different fractions of fruit extracts of six bayberry cultivars, were investigated for α-glucosidase inhibitory activities. The flavonol extracts (50% methanol elution fraction) of six cultivars showed strong α-glucosidase inhibitory activities (IC50 = 15.4-69.5 μg/mL), which were higher than that of positive control acarbose (IC50 = 383.2 μg/mL). Four purified compounds 1-4 exerted α-glucosidase inhibitory activities, with IC50 values of 1444.3 μg/mL, 418.8 μg/mL, 556.4 μg/mL, and 491.8 μg/mL, respectively. Such results may provide important evidence for the potential anti-diabetic activity of different cultivars of Chinese bayberry fruit and the possible bioactive compounds involved.Entities:
Keywords: Morella rubra fruit; flavonoid glycosides; purification; α-glucosidase inhibitory activity
Mesh:
Substances:
Year: 2016 PMID: 27589714 PMCID: PMC6273079 DOI: 10.3390/molecules21091148
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of four main flavonoid glycosides from Chinese bayberry pulp extract: cyanidin-3-O-glucoside (C3G) (1); myricetin-3-O-rhamnoside (M3R) (2); quercetin-3-O-galactoside (Q3Gal) (3); and quercetin-3-O-rhamnoside (Q3R) (4).
Figure 2Dynamic leakage curve (A); gradient elution curve (B); and isocratic desorption curve (C) of C3G on a Sep-Pak®.
Figure 3HPLC chromatogram of SPE column and semi-preparative HPLC (Prep-HPLC) purification procedure.
Figure 4LC-MS2 spectrum of four purified products.
Purities and recoveries of four flavonoid glycosides in the two-step purification procedure.
| Compounds | Purification Step | Purity (%) | Recovery (%) | Yield (mg) |
|---|---|---|---|---|
| C3G | ① Crude extract | 0.74 | / | / |
| ② SPE column | 54.12 | 90.75 | 620.4 1 | |
| ③ Prep-HPLC | 99.17 | 78.18 | 102.4 2 | |
| M3R | ① Crude extract | 0.02 | / | / |
| ② SPE column | 2.42 | 72.24 | 298.5 1 | |
| ③ Prep-HPLC | 90.38 | 71.58 | 4.6 3 | |
| Q3Gal | ① Crude extract | 0.06 | / | / |
| ② SPE column | 7.75 | 77.11 | 298.5 1 | |
| ③ Prep-HPLC | 94.57 | 79.32 | 15.6 3 | |
| Q3R | ① Crude extract | 0.03 | / | / |
| ② SPE column | 3.84 | 76.42 | 298.5 1 | |
| ③ Prep-HPLC | 93.61 | 77.20 | 7.6 3 |
1 The amount of sample was obtained from 50 g freeze dried raw material by the SPE column; 2 the amount of compound was obtained from 240 mg SPE column sample (10% fraction) by Pre-HPLC; 3 the amount of compound was obtained from 240 mg SPE column sample (50% fraction) by Pre-HPLC.
Figure 52.2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity (A) and 2.2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radical scavenging activity (B) of crude extract, fractions, and isolated and four purified compounds from BQ pulp. Data are presented as the mean ± SD (n = 3) and IC50 was calculated for each sample for both assays.
Figure 6Dose-dependent changes in α-glucosidase inhibition of crude extract, different fractions, and four purified compounds from BQ pulp. Data are presented as mean ± SD (n = 3) and acarbose is used as the positive control.
Figure 7Inhibition of α-glucosidase by crude extract, different fractions from five Chinese bayberry cultivars. IC50 values are presented as mean ± SD (n = 3).